Document

Is Subcutaneous Immunotherapy Ready for Prime Time? Join the June 23 webinar

Physicians are invited to join a panel of experts from Roswell Park Comprehensive Cancer Center on Tuesday, June 23 for a discussion on the use of subcutaneous immunotherapy.

Document

Join Roswell Park Expert at 2nd Annual Upstate Cancer Symposium June 21

The Oncology Brothers, including Roswell Park Comprehensive Cancer Center’s Rohit Gosain, MD, are hosting the second annual Upstate Cancer Symposium in Buffalo on June 21.

Video

New Immunotherapy Trials Offer Hope to Previously Excluded Gynecologic Cancer Patients

Roswell Park Comprehensive Cancer Center offers gynecologic cancer patients multidisciplinary care from nationally recognized specialists who collaborate on personalized treatment plans.

News

Roswell Park Announces Positive Progress in Clinical Trial of Novel Immunotherapy SurVaxM

Roswell Park Comprehensive Cancer Center  announced that the ongoing phase 2B SURVIVE clinical trial of SurVaxM in glioblastoma will continue following an interim analysis of trial data.

News

Brain Imaging Plus Virtual Reality Shows Promise for Effectively Managing Cancer Pain

 A clinical research study led by Roswell Park Comprehensive Cancer Center has identified a way to objectively measure pain in cancer patients and treat it effectively without opioids.

News

Immune Checkpoint Inhibitors ‘High-Risk Yet Promising’ for Cancer Patients Who Undergo Organ Transplant

A meta-analysis led by a researcher at Roswell Park Comprehensive Cancer Center has identified key factors that could improve outcomes for cancer patients treated with immune checkpoint inhibitors (ICIs) before or after a solid-organ transplant.